Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Janux Therapeutics, Inc. | 124,425 | reported | 02 Jan 2026 | tx 8+396,300−7,505 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | SALE | Janux Therapeutics, Inc. | 2,505 | 13.73 USD | |
| 02 Jan 2026 | GRANT_AWARD | Janux Therapeutics, Inc. | 31,400 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Janux Therapeutics, Inc. | 109,900 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 24,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 84,000 | 0.00 USD | deriv |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 4,325 | 46.21 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 675 | 47.22 USD | |
| 02 Jan 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 147,000 | 0.00 USD | deriv |